Cognitive decline linked to low serum TSH

Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Among nondemented elderly, low-normal serum thyroid stimulating hormone (TSH; <1.0 μIU/mL) was linked to cognitive decline.

Study design

  • Cross-sectional analysis of 293 healthy adults aged 65 y or older with normal TSH identified nondemented adults for follow-up (median, 16 mo): 95 with TSH ≥1.0 μIU/mL; 8 with TSH <1.0μIU/mL, untreated; and 7 with TSH <1.0 μIU/mL treated with methimazole.

Key results

  • Low-normal TSH was not associated with higher prevalence of dementia in the cross-sectional study.
  • Greatest declines on Mini Mental State Examination (MMSE) during follow-up were in untreated participants with TSH <1.0 μIU/mL; those receiving methimazole had less MMSE decline.
  • Depressive symptoms and Geriatric Depression Scale scores did not change during follow-up in participants with TSH <1.0 μIU/mL.

Limitations

  • Small sample of nondemented elderly with TSH <1.0 μIU/mL; lack of randomization or blinding.

Why this matters

  • Serum TSH levels increase with age. This increase has been associated with better outcomes among very elderly, but little was known about the association between low-normal TSH and health-related outcomes.
  • Elderly without dementia and low TSH should be monitored for cognitive decline to allow early intervention, including methimazole treatment if appropriate. Larger, randomized studies should help to inform such decisions.